Safety, efficacy and costs associated with direct coronary stenting compared with stenting after predilatation: A

Insights

Direct stenting is a safe and effective alternative to balloon predilatation for coronary artery stenting, offering similar clinical outcomes and modest cost savings. However, calcified lesions may predict unsuccessful direct stenting.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Coronary artery stenting is a common procedure for treating coronary artery disease.
  • Balloon predilatation is a standard step prior to stent implantation.
  • Direct stenting, bypassing balloon predilatation, may offer advantages.

Purpose of the Study:

  • To compare the in-hospital success rates, procedural costs, and short-term clinical outcomes of direct stenting versus stenting after balloon predilatation.
  • To identify predictors of procedural success in direct stenting.

Main Methods:

  • Randomized trial involving 400 patients with coronary stenoses.
  • Patients were assigned to either direct stenting or stenting after balloon predilatation.
  • Outcomes assessed included procedural success, clinical events, and procedural costs.

Main Results:

  • Procedural success rates were similar between groups (96.0% direct stenting vs. 94.5% predilatation).
  • Direct stenting showed modest cost savings (€2545 vs. €2763 per patient) due to reduced fluoroscopy time, contrast use, and balloon utilization.
  • Angiographic lesion calcification was an independent predictor of unsuccessful direct stenting (OR 7.1).
  • Major adverse cardiac events at 30 days were similar (4.5% vs. 5.5%).

Conclusions:

  • Direct stenting is a safe and effective alternative to balloon predilatation.
  • The procedure offers modest procedural cost savings.
  • Lesion calcification is a key factor predicting direct stenting success.
Abstract